Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products. | ||||||
Scipher Medicine is a precision immunology company that aims to match patients with their most effective therapy. Their proprietary platform, Spectra, combines AI and a network map of protein interactions in the human body to make predictions. | ||||||
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system. | ||||||
Develops novel cell and gene therapies with pharmacologic operating systems. | ||||||
Pliant Therapeutics is a clinical-stage biopharmaceutical company developing treatments for fibrotic diseases with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. | ||||||
Freeline Therapeutics Limited is a Stevenage, England-based biotechnology company developing liver directed gene therapies for a range of diseases. | ||||||
Kezar Life Sciences is a therapies for autoimmune disorders founded in 2015 by John Fowler. | ||||||
Delfi Diagnostics is a Baltimore, Maryland based company whose mission is to develop a blood test for cancer detection | ||||||
Repare Therapeutics is a synthetic Lethal Therapeutics founded in 2016 by Daniel Durocher, Agnel Sfeir and Frank Sicheri. | ||||||
Oncolytic Virus Cancer Immunotherapy | ||||||
Escient Pharmaceuticals is a GPCR-targeted Drugs founded in 2018. | ||||||
Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight. | ||||||
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases. | ||||||
Anaveon is a company founded in 2017. | ||||||
Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020. | ||||||
Aro Biotherapeutics is a protein Scaffolds founded in 2018. | ||||||
Non-degrading, molecular | ||||||